Spasmomen 40 mg FC tablets.
PDF Leaflet Revision Date: 15 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of irritable bowel syndrome (IBS) in adults.
Dosage (summary)
80-120 mg daily (1 tablet 2-3 times daily).
Special Populations
- Hepatic impairment
- Renal impairment
- Elderly patients
Pregnancy & Breastfeeding
Use only if necessary under medical supervision; limited data available.
Contraindications
- Hypersensitivity to otilonium bromide or excipients
Common side effects
- Headache
- Vertigo
- Dry mouth
- Nausea
- Upper abdominal pain
Counselling Points
- Swallow whole with water, preferably 20 mins before meals.
- Monitor for adverse reactions.
Serious warnings
- Caution in glaucoma, prostatic hypertrophy, pyloric stenosis
Important Disclaimer
The Spasmomen 40 mg FC tablets. professional information leaflet below is the property of Menarini South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
